The Therapeutic Use of 25% Human Serum Albumin in Critically Ill Dogs and Cats

Veterinary Clinics of North America - Small Animal Practice

Volumn 38, Issue 3, 2008, Pages 595-605

  Mathews, Karol A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FRESH FROZEN PLASMA; HUMAN SERUM ALBUMIN; RINGER LACTATE SOLUTION; SODIUM CHLORIDE;

ALBUMIN BLOOD LEVEL; BOLUS INJECTION; CAT DISEASE; COLLOID; CONTINUOUS INFUSION; CRITICAL ILLNESS; DISEASE SEVERITY; DOG DISEASE; DRUG INDICATION; DRUG USE; EDEMA; HOMEOSTASIS; HUMAN; HYPOALBUMINEMIA; HYPOTENSION; IMMUNE RESPONSE; NONHUMAN; ONCOTIC PRESSURE; OSMOLARITY; PLASMA TRANSFUSION; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VOMITING;

ANIMALS; BLOOD COAGULATION; CAT DISEASES; CATS; CRITICAL ILLNESS; DOG DISEASES; DOGS; FLUID THERAPY; HUMANS; SERUM ALBUMIN;

ANIMALIA; CANIS FAMILIARIS;

EID: 41549099130     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2008.02.004     Document Type: Review

References (57)

1. Brown J. Structural origins of mammalian albumin. Fed Proc 35 (1976) 2141-2144
2. Throop J.L., Bingaman S., and Huxley V. Differences between human and other mammalian albumins raises concerns over the use of human serum albumin in the dog. J Vet Intern Med 18 3 (2004) 439
3. Dixon F.J., Maurer P.H., and Deichmiller M.P. Half-lives of homologous serum albumin in several species. Proc Soc Exp Biol Med 83 (1953) 287-8
4. Mazzaferro E.M., Rudloff E., and Kirby R. The role of albumin replacement in the critically ill veterinary patient. Journal of Veterinary Emergency and Critical Care 12 2 (2002) 113-124
5. Powers K.A., Kapus A., Khadaroo R.G., et al. Twenty-five percent albumin prevents lung injury following shock/resuscitation. Crit Care Med 31 (2003) 2355-2363
6. Deb S., Sun I., and Martin B. Lactated Ringer's solution and hetastarch but not plasma resuscitation after rat hemorrhagic shock is associated with immediate lung apoptosis by the up-regulation of the Bax protein. J Trauma 49 (2000) 47-53
7. Zoellner H., Hou J.Y., and Lovery M. Inhibition of microvascular endothelial apoptosis in tissue explants by serum albumin. Microvasc Res 57 (1999) 162-173
8. Wheeler A.P., and Bernard G.R. Treating patients with sepsis. N Engl J Med 340 (1999) 207-214
9. Rothschild M.A., Oratz M., and Schreiber S.S. Albumin synthesis (second of two parts). N Engl J Med 286 15 (1972) 816-821
10. Guyton A.C., and Lindsey A.W. Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema. Circ res 7 (1959) 649-657
11. Martin G.S., and Bernard G.R. Airway and lung dysfunction in sepsis. Intensive Care Med 27 Suppl 1 (2001) 63-79
12. Ferguson N.D., Meade M.O., Hallett D.C., et al. High values of the pulmonary artery wedge pressure in patients with acute lung injury and acute respiratory distress syndrome. Intensive Care Med 28 (2002) 1073-1077
13. Sakka S.G., Klein M., Reinhart K., et al. Prognostic value of extra-vascular lung water in critically ill patients. Chest 122 (2002) 2080-2086
14. Smiley L.E. The use of hetastarch for plasma expansion. Probl Vet Med 4 4 (1992) 652-667
15. Rudloff E., and Kirby R. Hypovolemic shock and resuscitation. Vet Clin North Am Small Anim Pract 24 6 (1994) 1015-1039
16. Kirby R., and Rudloff E. The critical need for colloids: maintaining fluid balance. Compendium of Continuing Education for Practicing Veterinarians 19 (1997) 705-718
17. Rudloff E., and Kirby R. The critical need for colloids: selecting the right colloid. Compendium of Continuing Education for Practicing Veterinarians 19 (1997) 811-826
18. Rudloff E., and Kirby R. The critical need for colloids: administering colloids effectively. Compendium of Continuing Education for Practicing Veterinarians 20 (1998) 27-43
19. Rudloff E., and Kirby R. Fluid therapy. Crystalloids and colloids. Vet Clin North Am Small Anim Pract 28 (1998) 297-328
20. Weeren F.R., and Muir W.W. Clinical aspects of septic shock and comprehensive approaches to treatment in dogs. J Am Vet Med Assoc 200 12 (1992) 1859-1869
21. Holbeck S., and Grande P. Effects on capillary fluid permeability and fluid exchange of albumin, dextran, gelatin and hydroxyethyl starch in cat skeletal muscle. Crit Care Med 28 4 (2000) 1089-1095
22. Mishler J.M. Synthetic plasma volume expanders: their pharmacology, safety and clinical efficacy. Clin Haematol 13 (1984) 75-92
23. Nicholson J.P., Wolmarans M.R., and Park G.R. The role of albumin in critical illness. Br J Anaesth 85 (2000) 599-610
24. Hughes D. Fluid therapy with macromolecular plasma volume expanders. In: Di Bartola S.P. (Ed). Fluid therapy in small animal practice. 2nd edition (2000), WB Saunders, Philadelphia 483-495
25. Peters Jr. T. Serum albumin. Adv Protein Chem 37 (1985) 161-245
26. Emmerson Jr. T.E. Unique features of albumin: a brief review. Crit Care Med 17 (1989) 690-694
27. King T.P. On the sulfhydryl group of human plasma albumin. J Biol chem 236 2 (1961) PC5
28. Bourdon E., and Blache D. The importance of proteins in defense against oxidation. Antioxid Redox Signal 3 (2001) 293-311
29. Watts J.A., and Maiorano P.C. Trace amounts of albumin protect against ischemia and reperfusion injury in isolated rat hearts. J Mol Cell Cardiol 31 (1999) 1653-1662
30. Rhee P., Wang D., and Ruff P. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med 28 (2000) 74-78
31. Scatchard G., Batchelder A.C., and Brown A. Chemical, clinical and immunological studies on the products of human plasma fractionation. VI. The osmotic pressure of plasma and of serum albumin. J Clin Invest 23 (1944) 458-464
32. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomized controlled trials. BMJ 317 (1998) 235-240
33. Vincent J.L. Fluid management: the pharmacoeconomic dimension. Crit Care 4 Suppl 2 (2000) S33-S35
34. Choi P.T., Yip G., Quinonez L.G., et al. Crystalloids vs colloids in fluid resuscitation: a systematic review. Crit Care Med 27 (1999) 200-221
35. Allison S.P., and Lobo D.N. Debate: albumin administration should not be avoided. Crit Care 4 3 (2000) 147-150
36. Wilkes M.M., and Navickis R.J. Patient survival after human albumin administration. Ann Intern Med 135 (2001) 149-164
37. Boldt J. The good, the bad and the ugly: should we completely banish human albumin from our intensive care units?. Anesth Analg 91 (2000) 887-895
38. The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350 (2004) 2247-2256
39. Alderson F., Bunn A., Li Wan Po A., et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 4 (2004) CD001208
40. SAFE Study Investigators. Saline or albumin for fluid resuscitation in patients with TBI. N Engl J Med 357 (2007) 874-884
41. Vincent J.-L., Dubois M.-J., Navickis R.J., et al. Hypoalbuminemia in acute illness: is there a rationale for intervention. A meta-analysis of cohort studies and controlled trials. Ann Surg 237 3 (2003) 319-334
42. Vincent J.L. Fluids for resuscitation. Br J Anaesth 67 (1991) 185-193
43. Golub R., Sorrento Jr. J.J., Cantu Jr. R., et al. Efficacy of albumin supplementation in the surgical intensive care unit: a prospective, randomized study. Crit Care Med 22 4 (1994) 613-619
44. Dubois M.J., Orellana-Jimenez C., Melot C., et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 34 10 (2006) 2536-40
45. Abram-Ogg A.C.G. Practical blood transfusion. In: Day M.J., Mackin A., and Littlewood J.D. (Eds). BSAVA manual of canine and feline hematology and transfusion medicine (2000), British Small Animal Veterinary Association, Gloucester 263-303
46. Cotter S. Clinical transfusion medicine. Adv Vet Sci Comp Med 36 (1991) 187-223
47. Kristensen A.T. Administration of blood products to animals. In: Bistner S.I., and Ford R.B. (Eds). Kirk and Bistner's handbook of veterinary procedures and emergency treatment (1995), WB Saunders Co.,, Philadelphia 561-573
48. Chan D.L., Rozanski E.A., Freeman L.M., et al. Retrospective evaluation of human serum albumin use in critically ill dogs. [abstract]. Journal of Veterinary Emergency and Critical Care 14 Suppl 1 (2004) S8
49. Mathews K.A., and Barry M. The use of 25% human serum albumin: outcome and efficacy in raising serum albumin and systemic blood pressure in critically ill dogs and cats. Journal of Veterinary Emergency Critical Care 15 (2005) 110-118
50. Logan J.C., Callan M.B., Drew K., et al. Clinical indications for use of fresh frozen plasma in dogs: 74 dogs (October through December 1999). J Am Vet Med Assoc 218 (2001) 1449-1455
51. Harvey H.J. Complication of small intestinal biopsy in hypoalbuminemic dogs. Vet Surg 19 (1990) 289-292
52. Greissman A., Silver P., Nimkoff L., et al. Albumin bolus administration vs continuous infusion in critically ill hypoalbuminemic pediatric patients. Intensive Care Med 22 (1996) 495-499
53. Davidson A.P. Immune-mediated joint diseases. In: Slatter D.H. (Ed). Textbook of small animal surgery. 3rd edition (2003), WB Saunders Company, Philadelphia 2246-2250
54. Holden W., Orchard T., and Wordsworth P. Enteropathic arthritis. Rheum Dis Clin North Am 29 (2003) 513-530
55. Francis A., Martin L., Haldorson G.J., et al. Adverse reactions suggestive of type III hypersensitivity in six healthy dogs given human albumin. J Am Vet Med Assoc 230 6 (2007) 873-879
56. Mosley CA, Mathews KA. The use of concentrated bovine serum albumin in canines. In: Proceedings of the Annual Meeting of the American College of Veterinary Anesthesiologists. Phoenix, Arizona; 2004. p. 73.
57. Vincent J.L. Resuscitation using albumin in critically ill patients: research in patients at high risk of complications is now needed. BMJ 333 (2006) 1029-1030